: AKTS

AKTS

Stock Data

$25.00

$0.28 (1.13%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

All AKTS Articles

1 Article

Trey Thoelcke | Jan 19, 2026 at 8:45 AM EST

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

Alumis, Aktis Oncology, and W.R. Berkley saw the most prominent insider buying of the past week. There were a handful…

: AKTS

AKTS

$25.00

All AKTS Articles

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

The 5% Treasury Is Exposing Every Fake Dividend Stock

Alibaba or NetEase: Which Stock Could Soar After Earnings?

5 Strategic Buyers That Could Transform Aurora Innovation Into an Industry Powerhouse

Retirees Are Rooting for a Big 2027 COLA. A Large One Means Higher Medicare Premiums and a Bigger Tax Bill

Yelp's Chairman Used Under-the-Radar Roth Strategy to Get $95 Million Into His Account, And He Will Never Pay Another Dollar Of Tax On That Money. The Same Tax Rules Apply To You

Here Are Wednesday’s Top Wall Street Analyst Research Calls: Baidu, Ciena, CME Group, Dollar Tree, Dominion, Fabrinet, Honeywell Aerospace, Klarna, Pershing Square, and More

The 5% Treasury Is Exposing Every Fake Dividend Stock

: AKTS

AKTS

$25.00

All AKTS Articles

Huge Insider Buying Now at This Insurance Giant and 2 Biotechs

The 5% Treasury Is Exposing Every Fake Dividend Stock

Alibaba or NetEase: Which Stock Could Soar After Earnings?

5 Strategic Buyers That Could Transform Aurora Innovation Into an Industry Powerhouse

Featured Reads

Retirees Are Rooting for a Big 2027 COLA. A Large One Means Higher Medicare Premiums and a Bigger Tax Bill

Yelp's Chairman Used Under-the-Radar Roth Strategy to Get $95 Million Into His Account, And He Will Never Pay Another Dollar Of Tax On That Money. The Same Tax Rules Apply To You